Clinical pharmacology of the new penicillins. 1. The importance of serum protein binding in determining antimicrobial activity and concentration in serum.
about
Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillinTreatment with echinocandins during continuous renal replacement therapyCorrelation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein bindingDiagnostic treatment and reporting criteria for gonorrhoea in sexually transmitted disease clinics in England and Wales. 2: treatment and reporting criteria.Kinetic study of serum penicillin concentrations after single doses of benzathine and benethamine penicillins in young and old people.Single-dose oral treatment of gonorrhea in men and women, using ampicillin alone and combined with probenecid.Renal function, protein binding and pharmacological response to diazoxide.Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillinIn vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model.Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasisEffects of supraphysiologic temperature and broth dilution on serum protein binding.Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic modelAntimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infantsBinding of antibiotics to bovine and ovine serumSerum protein binding of the aminoglycoside antibioticsPaper disk-agar diffusion assay of penicillin in the presence of streptomycin.In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.Clinical pharmacology of mezlocillin.Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.Effect of ertapenem protein binding on killing of bacteria.Protein binding: do we ever learn?Septicemia.Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli.Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review.Clinical significance of protein binding of the penicillins.Evaluation of three newer methods for investigating protein interactions of penicillin G.Epicillin: in vitro laboratory studies.Comparison of broth and human serum as the diluent in the serum bactericidal test.Variation in performance of the serum bactericidal test.Displacement from protein binding of sulphormethoxine by phenylbutazone using in vivo dialysis in rats.Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administrationA study of the relationships between the sensitivities of Neisseria gonorrhoeae to sodium penicillin G, four semi-synthetic penicillins, spiramycin, and fusidic acid.Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery.The bioavailability of oral penicillin V. A comparative study of the absorption of different salts of penicillin V in children.Some determinants of the distribution of penicillins and cephalosporins in the body. Practical and theoretical considerations.Bioavailability of hetacillin in rats after liver enzyme induction by various inducers with or without protein binding properties.Protein Binding of First-Line Antituberculous Drugs.
P2860
Q24681732-40168D4E-68C4-4A48-B630-34DAC216B950Q27012864-B72C7247-D1BA-4F3B-B897-7320383502CBQ28353204-7EE2A9D1-DB7C-49D4-A00B-FCC451993DDEQ33655790-A921ED47-3A90-483B-95EC-B81464A452A6Q33657738-318AC0EF-4F8E-4F26-AD74-F26830931A74Q33666464-962967F0-47EB-456A-8480-42460F1F8C70Q34515000-29E897CB-C425-4C57-9B71-CD9258791D49Q34622703-5E4BCC93-88DE-432C-A708-98102D86C9B5Q34881676-98E66B56-6745-41AF-8632-AFCC86DD320DQ35007030-EC1F7240-188D-45B6-B4CE-10755FD47EFCQ35263450-C9F243B7-6CDA-43EE-B283-D216B5DA7B9FQ35276965-887832B7-66A6-4F72-AEE4-1D673DC0A13AQ35540563-FF594A17-AE14-41B5-9CBC-BD63A414D6CFQ35580401-881505A0-B4E3-4C95-A0BA-E427BB9EAC5DQ35643048-155E15D0-3629-4509-9C79-309A7501AA8FQ35643075-9E659756-DF4E-48DC-9EAF-20E982CC52FFQ35659146-24D3678D-B56E-4CD7-8D52-16119693F7B5Q36048229-D36E7FEA-8848-4CD2-B10B-AE7FC5A7AFC3Q36466089-CA6323AF-0B75-4548-9784-406515873A8DQ36863646-A76E5D20-39AE-4935-849C-FCA70D0BFBC8Q37149078-A1EE8498-7438-4D60-9264-4698F5894A09Q37488804-0DC862BD-362D-4D78-AA8C-9697AFEB1643Q37871252-438B5EC0-AA44-4C1A-A25A-5E7218EAFF14Q38332902-7DD872F3-314E-4911-937A-88665FA6F4D8Q39814757-AA8377F0-6957-45F7-B42F-8ECADA900AB0Q39934949-9844720E-E31A-408B-86C4-EDB3369A82F8Q40015195-26532EDF-1AAE-47A1-96A1-012C753FDF04Q40617526-7534C557-A605-42B2-8AC6-BE8DA1F3BCA2Q40885840-51914DE9-02C7-4379-B162-B768CCDDE6CEQ40943740-65A7FCD3-93CC-4BF5-B5D2-CF76FB5C4A76Q41030512-20D42AD5-7599-4801-9413-313020FA09AAQ41366106-7DA2D19E-5DC3-48F7-B900-935E3BFDF915Q41917434-30663DD4-DC73-4D83-9D39-969886BB0B2DQ42155947-BE9E3193-B9D8-4EBB-8ACA-5457B6F5C38AQ42632207-A621D973-CFDF-484F-87AB-26B9171D896DQ44135532-DA48A31A-ADEF-41A4-A753-42F7D2CCE4A0Q45079042-E8F29F3F-C4A8-49A5-B74B-C5B41DD626E2Q49321932-5A628CC7-119E-4567-8E64-D94218E668F6Q54218957-9A4DBEFA-60BA-4E64-82FB-B07E9AE7E03F
P2860
Clinical pharmacology of the new penicillins. 1. The importance of serum protein binding in determining antimicrobial activity and concentration in serum.
description
1966 nî lūn-bûn
@nan
1966年の論文
@ja
1966年学术文章
@wuu
1966年学术文章
@zh-cn
1966年学术文章
@zh-hans
1966年学术文章
@zh-my
1966年学术文章
@zh-sg
1966年學術文章
@yue
1966年學術文章
@zh
1966年學術文章
@zh-hant
name
Clinical pharmacology of the n ...... ty and concentration in serum.
@en
Clinical pharmacology of the n ...... ty and concentration in serum.
@nl
type
label
Clinical pharmacology of the n ...... ty and concentration in serum.
@en
Clinical pharmacology of the n ...... ty and concentration in serum.
@nl
prefLabel
Clinical pharmacology of the n ...... ty and concentration in serum.
@en
Clinical pharmacology of the n ...... ty and concentration in serum.
@nl
P356
P1476
Clinical pharmacology of the n ...... ty and concentration in serum.
@en
P2093
P304
P356
10.1002/CPT196672166
P407
P577
1966-03-01T00:00:00Z